ArticleBMC infectious diseases2026
Inpatients' willingness to accept antibiotic intravenous-to-oral switch therapy and its influencing factors: a qualitative study based on the Health Belief Model.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundAntimicrobial stewardship emphasizes the timely transition from intravenous to oral antibiotic therapy to reduce the risk of catheter-associated infections and shorten hospital stays. However, the overuse of intravenous antibiotics remains a significant issue in China. Understanding the factors that influence patients' willingness to accept intravenous-to-oral switch (IVOS) therapy from their perspective is essential. This study aims to explore inpatients' willingness to accept IVOS therapy and its potential influencing factors, based on the Health Belief Model (HBM), providing evidence for the development of more effective intervention strategies.
methodsBetween June and July 2025, a qualitative study guided by the HBM was conducted at a tertiary hospital in China. Fifteen inpatients receiving antibiotic therapy from five wards with high rates of intravenous antibiotic use were purposively selected for semi-structured interviews. Data were thematically analyzed and reported in accordance with the COREQ guidelines.
resultsThe study identified two themes and nine subthemes: (1) motivators to accept IVOS therapy (perceived benefits, high perceived severity, concerns about infusion safety, and action cues), (2) barriers to accept IVOS therapy (concerns about oral antibiotic effectiveness, low perceived susceptibility, low perceived severity, the "anti-inflammatory drug" label, and self-efficacy).
conclusionThis study indicates that patients lack sufficient awareness of the efficacy of oral antibiotics and the severity of antimicrobial resistance. Targeted interventions, particularly public education initiatives, can improve patient understanding of these issues, encourage more informed therapy decisions, and potentially increase acceptance of IVOS therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.